Koyfin Home > Directory > Health Care > Acceleron Pharma > Price / Book

Acceleron Pharma Price / Book Chart (XLRN)

Acceleron Pharma annual/quarterly Price / Book from 2013 to 2020. Price-to-book value (P/B) is the ratio of market value of a company's shares (share price) over its book value of equity. The book value of equity, in turn, is the value of a company's assets expressed on the balance sheet.
  • Acceleron Pharma Price / Book for the quarter ending September 09, 2020 was 13.69 a 4.39% increase of 0.60 year over year
  • Acceleron Pharma Price / Book for the last 12 months ending September 09, 2020 was 13.69 a 4.39% increase of 0.60 year over year
  • Acceleron Pharma Annual Price / Book for 2020 was 13.69 a 2.19% increase of 0.30 from 2019
  • Acceleron Pharma Annual Price / Book for 2020 was 13.39 a 2.89% increase of 0.39 from 2019
  • Acceleron Pharma Annual Price / Book for 2020 was 13.00 a -0.65% decrease of -0.08 from 2019
Other Valuation Metrics:
  • Acceleron Pharma Market Cap for the quarter ending March 03, 2018 was $1,776m a 33.91% increase of 602m year over year
  • Acceleron Pharma Enterprise Value for the quarter ending March 03, 2018 was $1,499m a 31.12% increase of 466m year over year
View Chart On Koyfin

Quarterly XLRN Price / Book Data

09/202013.69
09/202013.39
09/202013.00
09/202013.09
09/202012.72
09/202011.61
09/202011.45
09/202011.75
09/202011.48
09/202011.61

Annual XLRN Price / Book Data

202013.69
202013.39
202013.00
202013.09
202012.72
202011.61
202011.45
202011.75
202011.48
202011.61